Lexaria Bioscience Corp. (LEXX): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.66

Year ended 2025-08-31

2010-10-31 EPS (Diluted) (USD per share) 2025-08-31

Period ended	EPS (Diluted)	Change YoY	Source filing
2025-08-31	-$0.66	n/m	2025-11-28, From 2024-09-01
2024-08-31	-$0.47	n/m	2025-11-28, From 2023-09-01
2023-08-31	-$1.01	n/a	2024-11-26, From 2022-09-01
No annual figure between 2011-10-31 and 2023-08-31.
2011-10-31	-$0.04	n/m	2012-01-30, From 2010-11-01
2010-10-31	-$0.04	n/a	2012-01-30, From 2009-11-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Diluted)	Change YoY
Lexaria Bioscience Corp. (LEXX)	2025-08-31	-$0.66	n/m
Polomar Health Services, Inc. (PMHS)	2025-12-31	-$0.39	n/m
BioXcel Therapeutics, Inc. (BTAIQ)	2025-12-31	-$5.73	n/m
Hyperion Defi, Inc. (HYPD)	2025-12-31	-$9.40	n/m
Onconetix, Inc. (ONCO)	2025-12-31	-$16.56	n/m
Vaccinex, Inc. (VCNX)	2024-12-31	-$8.88	n/m
Rallybio Corp (RLYB)	2025-12-31	-$1.59	n/m
Yarrow Bioscience, Inc. (YARW)	2025-12-31	-$0.62	n/m
Silence Therapeutics plc (SLN)	2025-12-31	-$0.63	n/m

Compare LEXX, PMHS, BTAIQ, HYPD side by side · Screen every company in Pharmaceutical Preparations ↗